학술논문
Mass Switch From Intravenous to Subcutaneous Tocilizumab in Rheumatic Diseases During the SARS-COV-2 Pandemic.
Document Type
journal article
Author
Source
JRC: Journal of Clinical Rheumatology; Oct2022, Vol. 28 Issue 7, p346-348, 3p
Subject
Language
ISSN
10761608